Skill 5-7 | Administering a Subcutaneous Injection | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Skill Variation:Using an Insulin Injection Pen to Administer Insulin via the Subcutaneous Route Subcutaneous injections are administered into the adipose tissue layer just below the epidermis and dermis. This tissue has few blood vessels, so drugs administered here have a slow, sustained rate of absorption into the capillaries. Various sites may be used for subcutaneous injections, including the outer aspect of the upper arm, the abdomen (from below the costal margin to the iliac crests), the anterior aspects of the thigh, the upper back, and the upper ventral- or dorsogluteal area. Figure 1 displays the sites on the body where subcutaneous injections can be given. Absorption rates differ among the various sites. Injections in the abdomen are absorbed most rapidly; ones in the arms are absorbed somewhat more slowly; those in the thighs, even more slowly; and those in the ventral or dorsogluteal areas have the slowest absorption (American Diabetes Association [ADA], 2020). It is important to choose the right equipment to ensure depositing the medication into the intended subcutaneous tissue and not the underlying muscle. Equipment used for a subcutaneous injection includes a syringe of appropriate volume for the amount of drug being administered. A 25- to 30-gauge, ⅜;- to 1-inch needle can be used; the 25-gauge, ⅝;-inch needles are most commonly used for subcutaneous injections for adults (Taylor et al., 2023). Needle length ranges exist because patients present with different amounts of subcutaneous tissue that varies based on age, body mass index, and general build—choose the needle length based on the amount of subcutaneous tissue present (Shepherd, 2018b) and that ensures the needle terminates in the subcutaneous tissue (Taylor et al., 2023). Some medications are packaged in prefilled cartridges with a needle attached. One example is an insulin injection pen, which may be used for subcutaneous injection of insulin (see the accompanying Skill Variation for technique). Confirm that the provided needle is appropriate for the patient before use. If not, the medication will have to be transferred to another syringe and the appropriate needle attached. Subcutaneous injections are administered at a 45- or 90-degree angle, with the 45-degree angle used only for patients with a limited amount of subcutaneous tissue. Choose the angle of needle insertion based on the amount of subcutaneous tissue present and the length of the needle. In general, insert the shorter, ⅜;-inch needle, at a 90-degree angle (common on prefilled and insulin syringes). The longer, ⅝;-inch needle, may be inserted at a 45-degree angle. Figure 5-1 in the chapter opener on page 200 shows the angles of insertion for subcutaneous injections. Usually, no more than 1 mL of solution is given subcutaneously. Giving larger amounts adds to the patient's discomfort and may predispose to poor absorption. It is necessary to rotate sites or areas for injection if the patient is to receive frequent injections. This helps to prevent buildup of fibrous/adipose tissue and permits complete absorption of the medication. Further information regarding insulin administration and rotation of injection sites can be found in the General Considerations at the end of this skill. Box 5-1 discusses techniques for reducing discomfort when injecting medications subcutaneously or intramuscularly. Delegation Considerations The administration of a subcutaneous injection is not delegated to assistive personnel (AP). Depending on the state's nurse practice act and the organization's policies and procedures, the administration of a subcutaneous injection may be delegated to licensed practical/vocational nurses (LPN/LVNs). The decision to delegate must be based on careful analysis of the patient's needs and circumstances as well as the qualifications of the person to whom the task is being delegated. Refer to the Delegation Guidelines in Appendix A. Equipment
Assessment Assess the appropriateness of the drug for the patient. Review the medical history and allergy, assessment, and laboratory data that may influence drug administration. Check the expiration date before administering the medication. Assess the site on the patient where the injection is to be given. Avoid sites that are bruised, tender, hard, swollen, inflamed, or scarred. These conditions could affect the reliability of absorption (ADA, 2020; Gelder, 2014). Assess the patient's knowledge of the medication. If the patient has deficient knowledge about the medication, this may be the appropriate time to begin education about it. If the medication may affect the patient's vital signs, assess them before administration. If the medication is for pain relief, assess the patient's pain before and after administration. Verify patient name, dose, route, and time of administration. Actual or Potential Health Problems and Needs Many actual or potential health problems or issues may require the use of this skill as part of related interventions. An appropriate health problem or issue may include: Outcome Identification and Planning The expected outcomes to achieve are that the patient receives the medication via the subcutaneous route and experiences the intended effect of the medication. Other outcomes that may be appropriate include the following: the patient does not experience adverse effects, and the patient understands and engages with the medication regimen. Implementation
Documentation Guidelines Record each medication given on the eMAR/MAR or health record using the required format immediately after administration, including date, dose, time, and the site of administration. If using a bar-code system, medication administration is automatically recorded when the bar code is scanned. PRN medications require documentation of the reason for administration. Prompt recording avoids the possibility of accidentally repeating the administration of the drug. If the drug was refused or omitted, record this in the appropriate area on the medication record and notify the health care team as appropriate. This verifies the reason medication was omitted and ensures that health care personnel providing care for the patient are aware of the occurrence. Developing Clinical Reasoning and Clinical Judgment Unexpected Situations and Associated Interventions
Special Considerations General Considerations
Community-Based Care Considerations
Using an Insulin Injection Pen to Administer Insulin via the Subcutaneous Route Prepare medication as outlined in Steps 1-23 above (Skill 5-7).
Source: Adapted from Becton, Dickinson and Company. (2021a). Injecting insulin with a pen. https://www.bd.com/en-uk/products/diabetes/diabetes-learning-centre/injection-technique/injecting-insulin-with-a-pen; Becton, Dickinson and Company. (2021b). BD AutoShield Duo pen needle. https://www.bd.com/en-us/offerings/capabilities/diabetes-care/pen-needles/bd-autoshield-duo-pen-needle-x857469. |